Prothena to Initiate PRONTO, a Global Trial of NEOD001 in Patients With AL Amyloidosis With Primary Endpoint of Cardiac Response
Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news
More News: Amyloidosis | Pharmaceuticals